FIELD: chemistry.
SUBSTANCE: invention relates to peptides, which include phycocyanobilin (PCB), and medical application of said peptides and PCB, due to identified in them neuroprotective and/or neuroregenerative activity.
EFFECT: pharmaceutical combinations of said peptides and PCB with proteins or other peptides with synergetic effect can be applied for treatment of ischemic or neurodegenerative CNS diseases.
12 cl, 9 dwg, 2 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT CHIMERIC PROTEIN ANTH1, NUCLEIC ACID ENCODING ITS AND THEIR USING | 2003 |
|
RU2322455C2 |
CONJUGATES FOR ADMINISTERING BIOLOGICALLY ACTIVE COMPOUNDS | 2009 |
|
RU2567667C2 |
FUSED IMMUNOGLOBULIN PROTEINS | 2008 |
|
RU2530168C2 |
USE OF PEPTIDE THAT ENHANCES SECRETION OF SOMATOTROPIC HORMONE AS VACCINE ADJUVANT | 2017 |
|
RU2768134C2 |
APPLICATION OF INHIBITING TGF-beta1 PEPTIDES FOR PREPARATION OF AGENT MODULATING IMMUNE RESPONSE | 2005 |
|
RU2420307C2 |
PEPTIDE ANALOGUE COMPOUNDS OF GROWTH HORMONE SECRETION STIMULANTS AND PREPARATIONS CONTAINING SAID COMPOUNDS | 2007 |
|
RU2416618C2 |
PEPTIDE CONJUGATED PARTICLES | 2014 |
|
RU2685186C2 |
APOPTOSIS INHIBITORS AND USE THEREOF | 2011 |
|
RU2582247C2 |
IMMUNOMODULATORY AND ANTINEOPLASTIC PEPTIDES | 2007 |
|
RU2430109C2 |
CONJUGATES AND COMPOSITIONS FOR IMMUNOTHERAPY AND ANTICANCER TREATMENT | 2010 |
|
RU2597989C2 |
Authors
Dates
2015-11-20—Published
2012-06-29—Filed